Application | Comment | Organism |
---|---|---|
medicine | molecular mechanism by which neurofibrillary degeneration occurs in adults with Down syndrome | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
cytoplasm | - |
Homo sapiens | 5737 | - |
nucleus | - |
Homo sapiens | 5634 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | Q13627 | adult patients with Down syndrome | - |
Purification (Comment) | Organism |
---|---|
gel filtration | Homo sapiens |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
brain | - |
Homo sapiens | - |
neuron | - |
Homo sapiens | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
additional information | - |
presence of an extra copy of the Dyrk1A gene due to trisomy 21 results in overexpression of Dyrk1A and elevated kinase activity in brain of Down syndrome patients, tau phosphorylation, enzyme kinetics, and Dyrk1A kinase assays, nuclear and cytoplasmic Dyrk1A may contribute to Down syndrome via different mechanisms | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
additional information | participation in regulating tau phosphorylation, provides a novel mechanism leading to neurofibrillary pathology in Down syndrome | Homo sapiens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
DYRK1A | - |
Homo sapiens |